Issues lobbied + lobbyists (5)
BUD — Budget/Appropriations
Funding related to biomedical and cancer research and innovation at the NIH and NCI, funding for Childhood Cancer research, funding for ARPA-H in the Labor, Health and Human Services, Education bill; funding for cancer prevention and smoking cessation programs at the CDC.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
HCR — Health Issues
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/Medicaid
Issues related to health care access and reimbursement through the Medicare and Medicaid programs including site neutrality and prior authorization policies in the Medicare and Medicare Advantage program
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MED — Medical/Disease Research/Clinical Labs
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TOB — Tobacco
Support for FDA's role to vigorously enforce the Family Smoking Prevention and Tobacco Control Act including the regulation of flavors, menthol and small cigars. Support for continued funding for the CDCs Office on Smoking and Health.
Government entities lobbied: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; President of the U.S.; SENATE